tirzepatide type of drug enhances weight loss with sustained treatment but discontinuation leads to weight regain FDA approves tirzepatide, Eli Lilly's

It is a valid question, as the form and quality of a supplement can significantly influence how your body responds

Ozempic and Rybelsus carry EMA centralised authorisation for type-2 diabetes

Furthermore, in view of the ongoing uncertainty around whether incretin drugs increase the risk of non-arteritis anterior ischaemic optic neuropathy (NAION) (Etminanet al, 2025), we need to warn people to seek urgent medical advice if they suffer eye symptoms during treatment with these drugs

NICE guidance (CG173) on neuropathic pain recommends duloxetine as first-line treatment for painful diabetic neuropathy

Our comprehensive panel looks beneath the surface to provide a detailed baseline or progress report across these key areas

Sample Dosing Protocols for Your Study Now, let's talk numbers